NASDAQ:BNTX
BioNTech SE
- Stock
locale
Germany
market
STOCKSindustry
Biotechnologywebsite
www.biontech.deipo date
Oct 10, 2019
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV+ hea...Show More
Earnings
Earnings Release in 9 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus